Literature DB >> 26863382

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation.

Nir Qvit1, Opher S Kornfeld2.   

Abstract

Protein-protein interactions (PPIs) are intimately involved in almost all biological processes and are linked to many human diseases. Therefore, there is a major effort to target PPIs in basic research and in the pharmaceutical industry. Protein-protein interfaces are usually large, flat, and often lack pockets, complicating the discovery of small molecules that target such sites. Alternative targeting approaches using antibodies have limitations due to poor oral bioavailability, low cell-permeability, and production inefficiency. Using peptides to target PPI interfaces has several advantages. Peptides have higher conformational flexibility, increased selectivity, and are generally inexpensive. However, peptides have their own limitations including poor stability and inefficiency crossing cell membranes. To overcome such limitations, peptide cyclization can be performed. Cyclization has been demonstrated to improve peptide selectivity, metabolic stability, and bioavailability. However, predicting the bioactive conformation of a cyclic peptide is not trivial. To overcome this challenge, one attractive approach it to screen a focused library to screen in which all backbone cyclic peptides have the same primary sequence, but differ in parameters that influence their conformation, such as ring size and position. We describe a detailed protocol for synthesizing a library of backbone cyclic peptides targeting specific parasite PPIs. Using a rational design approach, we developed peptides derived from the scaffold protein Leishmania receptor for activated C-kinase (LACK). We hypothesized that sequences in LACK that are conserved in parasites, but not in the mammalian host homolog, may represent interaction sites for proteins that are critical for the parasites' viability. The cyclic peptides were synthesized using microwave irradiation to reduce reaction times and increase efficiency. Developing a library of backbone cyclic peptides with different ring sizes facilitates a systematic screen for the most biological active conformation. This method provides a general, fast, and facile way to synthesize cyclic peptides.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26863382      PMCID: PMC4781697          DOI: 10.3791/53589

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  73 in total

1.  Medicine. Targeting apoptotic pathways in cancer cells.

Authors:  Catherine Denicourt; Steven F Dowdy
Journal:  Science       Date:  2004-09-03       Impact factor: 47.728

Review 2.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

3.  Efficient microwave-assisted tandem N- to S-acyl transfer and thioester exchange for the preparation of a glycosylated peptide thioester.

Authors:  Fumihiro Nagaike; Yuko Onuma; Chie Kanazawa; Hironobu Hojo; Akiharu Ueki; Yuko Nakahara; Yoshiaki Nakahara
Journal:  Org Lett       Date:  2006-09-28       Impact factor: 6.005

4.  Rapid solid-phase synthesis of a calmodulin-binding peptide using controlled microwave irradiation.

Authors:  Bernadett Bacsa; C Oliver Kappe
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 5.  Rationally designed peptide regulators of protein kinase C.

Authors:  Eric N Churchill; Nir Qvit; Daria Mochly-Rosen
Journal:  Trends Endocrinol Metab       Date:  2008-12-04       Impact factor: 12.015

6.  Expression cloning of a protective Leishmania antigen.

Authors:  E Mougneau; F Altare; A E Wakil; S Zheng; T Coppola; Z E Wang; R Waldmann; R M Locksley; N Glaichenhaus
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

7.  Positional scanning for peptide secondary structure by systematic solid-phase synthesis of amino lactam peptides.

Authors:  Andrew G Jamieson; Nicolas Boutard; Kim Beauregard; Mandar S Bodas; Huy Ong; Christiane Quiniou; Sylvain Chemtob; William D Lubell
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

8.  Update of alpha fetoprotein growth-inhibitory peptides as biotherapeutic agents for tumor growth and metastasis.

Authors:  G J Mizejewski; M Muehlemann; M Dauphinee
Journal:  Chemotherapy       Date:  2006-02-22       Impact factor: 2.544

9.  Novel Gly building units for backbone cyclization: synthesis and incorporation into model peptides.

Authors:  Sharon Gazal; Gary Gellerman; Chaim Gilon
Journal:  Peptides       Date:  2003-12       Impact factor: 3.750

10.  Design and synthesis of backbone cyclic phosphorylated peptides: The IkappaB model.

Authors:  Nir Qvit; Ada Hatzubai; Deborah E Shalev; Assaf Friedler; Yinon Ben-Neriah; Chaim Gilon
Journal:  Biopolymers       Date:  2009-02       Impact factor: 2.505

View more
  3 in total

Review 1.  Peptides and peptidomimetics as regulators of protein-protein interactions.

Authors:  Anna D Cunningham; Nir Qvit; Daria Mochly-Rosen
Journal:  Curr Opin Struct Biol       Date:  2017-01-04       Impact factor: 6.809

Review 2.  The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained.

Authors:  Amit U Joshi; Opher S Kornfeld; Daria Mochly-Rosen
Journal:  Cell Calcium       Date:  2016-05-07       Impact factor: 6.817

3.  Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors.

Authors:  Nir Qvit; Deborah Schechtman; Darlene Aparecida Pena; Denise Aparecida Berti; Chrislaine Oliveira Soares; Qianqian Miao; Liying Annie Liang; Lauren A Baron; Christian Teh-Poot; Pedro Martínez-Vega; Maria Jesus Ramirez-Sierra; Eric Churchill; Anna D Cunningham; Andrey V Malkovskiy; Nancy A Federspiel; Fabio Cesar Gozzo; Ana Claudia Torrecilhas; Maria Julia Manso Alves; Armando Jardim; Ndao Momar; Eric Dumonteil; Daria Mochly-Rosen
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-02-12       Impact factor: 4.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.